Cryofocus Medtech (Shanghai) Co (HKSE:06922) EV-to-EBIT : -15.56 (As of May. 12, 2024)

View and export this data going back to 2022. Start your Free Trial

What is Cryofocus Medtech (Shanghai) Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Cryofocus Medtech (Shanghai) Co's Enterprise Value is HK$1,789.02 Mil. Cryofocus Medtech (Shanghai) Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-114.95 Mil. Therefore, Cryofocus Medtech (Shanghai) Co's EV-to-EBIT for today is -15.56.

The historical rank and industry rank for Cryofocus Medtech (Shanghai) Co's EV-to-EBIT or its related term are showing as below:

HKSE:06922' s EV-to-EBIT Range Over the Past 10 Years
Min: -32.03 Med: -27.83 Max: -12.05
Current: -15.56

During the past 4 years, the highest EV-to-EBIT of Cryofocus Medtech (Shanghai) Co was -12.05. The lowest was -32.03. And the median was -27.83.

HKSE:06922's EV-to-EBIT is ranked worse than
100% of 455 companies
in the Medical Devices & Instruments industry
Industry Median: 20.82 vs HKSE:06922: -15.56

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Cryofocus Medtech (Shanghai) Co's Enterprise Value for the quarter that ended in Jun. 2023 was HK$4,106.17 Mil. Cryofocus Medtech (Shanghai) Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-114.95 Mil. Cryofocus Medtech (Shanghai) Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 was -2.80%.

Cryofocus Medtech (Shanghai) Co EV-to-EBIT Historical Data

The historical data trend for Cryofocus Medtech (Shanghai) Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cryofocus Medtech (Shanghai) Co EV-to-EBIT Chart

Cryofocus Medtech (Shanghai) Co Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

EV-to-EBIT

-30.46

-38.38

Cryofocus Medtech (Shanghai) Co Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-EBIT	Get a 7-Day Free Trial			-	-	-30.46	-	-

Competitive Comparison of Cryofocus Medtech (Shanghai) Co's EV-to-EBIT

For the Medical Devices subindustry, Cryofocus Medtech (Shanghai) Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Cryofocus Medtech (Shanghai) Co's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Cryofocus Medtech (Shanghai) Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Cryofocus Medtech (Shanghai) Co's EV-to-EBIT falls into.

Cryofocus Medtech (Shanghai) Co EV-to-EBIT Calculation

Cryofocus Medtech (Shanghai) Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT	=	Enterprise Value (Today)	/	EBIT (TTM)
	=	1789.023	/	-114.951
	=	-15.56

Cryofocus Medtech (Shanghai) Co's current Enterprise Value is HK$1,789.02 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cryofocus Medtech (Shanghai) Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-114.95 Mil.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Cryofocus Medtech (Shanghai) Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Jun. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Jun. 2023 )	=	EBIT	/	Enterprise Value (Q: Jun. 2023 )
	=	-114.951	/	4106.1748
	=	-2.80 %

Cryofocus Medtech (Shanghai) Co's Enterprise Value for the quarter that ended in Jun. 2023 was HK$4,106.17 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Cryofocus Medtech (Shanghai) Co's EBIT for the trailing twelve months (TTM) ended in Jun. 2023 was HK$-114.95 Mil.

Cryofocus Medtech (Shanghai) Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Cryofocus Medtech (Shanghai) Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Cryofocus Medtech (Shanghai) Co Ltd (HKSE:06922) » Definitions » EV-to-EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Building 15, Lane 3399, Kangxin Road, Pudong New Area, Shanghai, CHN, 200120

Website

https://www.cryofocus.com

Cryofocus Medtech (Shanghai) Co Ltd is a medical device company engaged in the research and development, manufacture and sale of cryoablation minimally-invasive interventional treatment technology and related medical products. It has two Core Products, the Bladder Cryoablation System and the Endoscopic Clip for Anastomosis. The Bladder Cryoablation System is a cryotherapy device designed for the treatment of bladder cancer. The Endoscopic Clip for Anastomosis is an anastomotic device for the closure of soft tissue in the digestive tract, which is one of the over-the-scope clips. Geographically company's key revenue is generated from China.

Cryofocus Medtech (Shanghai) Co (HKSE:06922) Headlines

No Headlines